NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of 10.3% from 2019 to 2025. Factors driving the market growth are; rising prevalence of neurological diseases across the globe, government initiative for product approvals and investments, and rising geriatric population across the globe. In addition, growing use in SCS technology, increasing awareness for neuromodulation, and new product launches are further boosting the industry growth.
Neuromodulation devices are advanced medical tools that improve nervous system activities. Neuromodulation devices affect every area of the body and treat nearly every disease such as spinal cord damage, headaches, tremors, and urinary incontinence, among others. Moreover, these devices have a broad therapeutic scope, and significant ongoing improvements in biotechnology sector are resulting in major growth of the market.
Additionally, there is an increased demand for neuromodulation devices due to growing aging population which suffers from diseases such as Parkinson, epilepsy, Alzheimer’s, and spinal cord injury. The therapies for these diseases are dominated by neuromodulation devices. Moreover, clinical evidence supporting the use of neurostimulation to treat multiple conditions and growing investments in product development is further driving the industry growth.
Browse full research report with TOC on " Global Neuromodulation Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025" at: https://www.energiasmarketresearch.com/global-neuromodulation-devices-market-report/
To purchase report: sales@energiasmarketresearch.com
Key findings from the report:
• The global neuromodulation devices market is expected to reach USD 10,200 Million by 2025 at a CAGR of 10.3% during 2019-2025
• Based on Technology,
• On the basis of Application, the Pain Management segment held the major share of the market in 2018
• Geographically, Asia-Pacific region is expected to witness highest CAGR during the 2019-2025
• Some of the key companies operating in the market include Medtronic; NeuroPace, Inc.; Abbot; Boston Scientific Corporation; ALEVA NEUROTHERAPEUTICS SA; Stimwave LLC; Nevro Corp.; Integer Holdings Corporation; Bioness Inc.; and LivaNova PLC, among others
The report provides the market value for the base year 2018 and a yearly forecast till 2025 in terms of revenue (USD Million). The report segments neuromodulation devices market on the basis of technology, application, end-user, and region.
By Technology
• Internal Neuromodulation
• External Neuromodulation
By Application
By End-User
By Region
Find more research reports on Healthcare Industry, by Energias Market Research:
About Energias Market Research Pvt. Ltd. -
Energias Market Research launched with the objective to provide in-depth market analysis, business research solutions, and consultation that is tailored to our client’s specific needs based on our impeccable research methodology.
With a wide range of expertise from various industrial sectors and more than 50 industries that include energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.
Our comprehensive industry-specific knowledge enables us in creating high quality global research outputs. This wide-range capability differentiates us from our competitors.
Contact:
Mr. Alan Andrews
Business Development Manager
For any queries email us: info@energiasmarketresearch.com
To purchase report: sales@energiasmarketresearch.com
Call us: +1-716-239-4915
Visit: https://www.energiasmarketresearch.com/